SI1620113T1 - Topikalna formulacija ivermectina za zdravljenje dermatoloških obolenj - Google Patents

Topikalna formulacija ivermectina za zdravljenje dermatoloških obolenj

Info

Publication number
SI1620113T1
SI1620113T1 SI200431722T SI200431722T SI1620113T1 SI 1620113 T1 SI1620113 T1 SI 1620113T1 SI 200431722 T SI200431722 T SI 200431722T SI 200431722 T SI200431722 T SI 200431722T SI 1620113 T1 SI1620113 T1 SI 1620113T1
Authority
SI
Slovenia
Prior art keywords
ivermectin
treatment
topical formulation
dermatological conditions
dermatological
Prior art date
Application number
SI200431722T
Other languages
English (en)
Inventor
Vincent Manetta
Gary R Watkins
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33104376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1620113(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Sa filed Critical Galderma Sa
Priority claimed from PCT/EP2004/004950 external-priority patent/WO2004093886A1/en
Publication of SI1620113T1 publication Critical patent/SI1620113T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200431722T 2003-04-24 2004-04-22 Topikalna formulacija ivermectina za zdravljenje dermatoloških obolenj SI1620113T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0305048A FR2854074B1 (fr) 2003-04-24 2003-04-24 Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US46899403P 2003-05-09 2003-05-09
PCT/EP2004/004950 WO2004093886A1 (en) 2003-04-24 2004-04-22 Topical formulation of ivermectin for the treatment of dermatological conditions
EP04728811A EP1620113B1 (en) 2003-04-24 2004-04-22 Topical formulation of ivermectin for the treatment of dermatological conditions

Publications (1)

Publication Number Publication Date
SI1620113T1 true SI1620113T1 (sl) 2011-10-28

Family

ID=33104376

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431722T SI1620113T1 (sl) 2003-04-24 2004-04-22 Topikalna formulacija ivermectina za zdravljenje dermatoloških obolenj

Country Status (11)

Country Link
US (6) US8815816B2 (sl)
KR (1) KR101291824B1 (sl)
CN (2) CN1777433A (sl)
AR (1) AR044050A1 (sl)
AT (1) ATE516037T1 (sl)
DK (1) DK1620113T3 (sl)
ES (1) ES2371945T3 (sl)
FR (1) FR2854074B1 (sl)
PT (1) PT1620113E (sl)
SI (1) SI1620113T1 (sl)
ZA (1) ZA200507346B (sl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2883181B1 (fr) 2005-03-17 2007-05-18 Galderma Sa Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
EP2653160B1 (en) 2006-10-12 2017-09-27 Topaz Pharmaceuticals Inc. Topical ivermectin formulations and methods for elimination and prophylaxis of body lice
US7953614B1 (en) 2006-11-22 2011-05-31 Dr Systems, Inc. Smart placement rules
MX2011004442A (es) * 2008-10-29 2011-10-14 Topaz Pharmaceuticals Inc Sistema conservante para formulaciones topicas terapeuticas basadas en emulsion.
CN102784166B (zh) * 2012-08-01 2015-11-25 青岛绿曼生物工程有限公司 治疗家畜螨虫病的复方伊维菌素组合物及其制备方法
CN103356687B (zh) 2012-10-19 2016-06-01 厦门大学 一种伊维菌素及其衍生物的用途
US9233118B2 (en) * 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US20170000812A1 (en) 2013-11-29 2017-01-05 Galderma S.A. Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
RU2016141961A (ru) 2014-03-28 2018-04-28 Галдерма Ресерч Энд Девелопмент Несмываемая химическая пена, содержащая пероксид бензоила
CN104127334A (zh) * 2014-08-19 2014-11-05 杨人源 一种杀菌除螨宠物香波
EP3220903A1 (fr) * 2014-11-20 2017-09-27 Galderma S.A. Compositions comprenant un compose de la famille des avermectines et un compose agoniste d'au moins un des recepteurs de l'acide retinoique pour le traitement de l'acne
FR3041537B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
FR3041540B1 (fr) * 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine.
FR3041539B1 (fr) 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041536B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041538B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041535B1 (fr) 2015-09-29 2019-01-25 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041541B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
WO2017064205A1 (en) * 2015-10-13 2017-04-20 Galderma Sa A process for preparing a stable emulsion comprising one or more avermectins
WO2018060870A1 (en) * 2016-09-30 2018-04-05 Aurobindo Pharma Limited Pharmaceutical composition of ivermectin and process for preparation thereof
TR201714097A2 (tr) * 2017-09-22 2018-10-22 Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi İvermekti̇n topi̇k formülasyon
KR20200111177A (ko) 2017-12-15 2020-09-28 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
US20210077559A1 (en) * 2018-01-05 2021-03-18 Attillaps Holdings Treating Autoimmune Disorders with Acetylcholinesterase Inhibitors
WO2019152560A1 (en) * 2018-01-31 2019-08-08 Bio33 Degrees, Inc. Compositions and methods for topical treatment of dermal and ocular conditions
CN108272750A (zh) * 2018-04-25 2018-07-13 菏泽学院 一种治疗动物皮肤疥癣病的软膏剂及其制备方法
WO2021247283A1 (en) * 2020-06-04 2021-12-09 Amcyte Pharma, Inc. Delivery of aerosolized micromolar composition concentrations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197796A (en) 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
FR2725369B1 (fr) * 1994-10-07 1997-01-03 Oreal Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
US5656280A (en) 1994-12-06 1997-08-12 Helene Curtis, Inc. Water-in-oil-in-water compositions
WO1997011709A1 (en) 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
FR2754452B1 (fr) 1996-10-11 2003-02-14 Oreal Emulsion h/e a forte teneur en electrolytes et leur utilisation en dermo-cosmetique, notamment pour traiter les phenomenes d'irritation et/ou de peaux sensibles
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
FR2787322B1 (fr) 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
EP1476121A4 (en) 2002-02-08 2010-10-27 Merck Sharp & Dohme TOPICAL IVERMECTIN COMPOSITION
EP1480633A2 (en) 2002-03-04 2004-12-01 Divergence, Inc. Nematicidal fatty acid and fatty acid ester related compounds
JP5711867B2 (ja) 2003-04-24 2015-05-07 ガルデルマ・ソシエテ・アノニム 皮膚科学的疾患の治療のためのアイバメクチンの使用
FR2867684B1 (fr) 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme

Also Published As

Publication number Publication date
ATE516037T1 (de) 2011-07-15
CN1777433A (zh) 2006-05-24
US11033565B2 (en) 2021-06-15
DK1620113T3 (da) 2011-09-12
KR101291824B1 (ko) 2013-07-31
US20140051653A1 (en) 2014-02-20
CN103800353A (zh) 2014-05-21
PT1620113E (pt) 2011-09-12
FR2854074B1 (fr) 2007-11-23
US20150306027A1 (en) 2015-10-29
AR044050A1 (es) 2005-08-24
US20170281664A1 (en) 2017-10-05
FR2854074A1 (fr) 2004-10-29
US8815816B2 (en) 2014-08-26
ES2371945T3 (es) 2012-01-11
ZA200507346B (en) 2006-08-30
US20170281663A1 (en) 2017-10-05
US20150306124A1 (en) 2015-10-29
KR20120062028A (ko) 2012-06-13
US20140336139A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
HUS1500048I1 (hu) Ivermectin helyi kiszerelése dermatológiai állapotok kezelésére
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
TWI345979B (en) Topical pharmaceutical compositions for the treatment of dermatitis
HK1073997A1 (en) Administration of agents for the treatment of inflammation
AU2003300791A1 (en) Combination therapy for the treatment of pain
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
AU2003285281A8 (en) Topical application of curcumin for the treatment of peripheral neuropathy
AU2002368219A1 (en) Dermatological preparation for the treatment of skin lesions
ZA200405853B (en) Use of adapalene for the treatment of dermatological disorders
AU2003251407A1 (en) Topical treatment for skin irritation
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
AU2003252187A1 (en) Topical composition for the treatment of inflammatory conditions of the skin
AU2003252185A1 (en) Topical composition for the treatment of scar tissue
AU2002331892A1 (en) Topical pharmaceutical composition to treat hyperpigmentation of the skin
AU2003213349A1 (en) Therapeutic agent for pain
AU2003905303A0 (en) Skin Treatment Formulation
AU2003902930A0 (en) Pharmaceutical composition for the treatment of skin conditions
ZA200410074B (en) Topical composition for the treatment of inflammatory conditions of the skin
AU2003210347A1 (en) Cathepsin y for the treatment of pain
AU2002950148A0 (en) Pharmaceutical composition for the treatment of skin conditions
AUPR637001A0 (en) Pharmaceutical composition for the treatment of skin conditions
AU2004905636A0 (en) Skin Treatment Formulation
GB0303885D0 (en) Therapeutic preparations for the therapy of dermatoses